健康老年人低密度脂蛋白胆固醇与死亡结局:ASPREE试验事后分析
限制性立方样条显示LDL-c与全因、癌症及非癌非心血管死亡呈U形关系(最低点3.3-3.4 mmol/L),而心血管死亡风险在LDL-c高于3.3 mmol/L时升高。
要点
- 健康老年人LDL-c与全因、癌症及非癌非心血管死亡呈U形关系,最低点约3.3-3.4 mmol/L。
- LDL-c每升高1 mmol/L,全因死亡风险降低9%,癌症死亡降低16%,非癌非心血管死亡降低18%。
- LDL-c每升高1 mmol/L,心血管死亡风险增加19%;降低全因及非心血管死亡风险仅见于男性。
核心结论
- 健康老年人LDL-c与全因死亡、癌症死亡及非癌非心血管死亡呈U形关系。
- 较高LDL-c水平与心血管死亡风险增加相关。
研究设计与样本
- 基线无痴呆、躯体失能或心血管病,且未服用降脂药物。
- 采用多变量Cox模型分析LDL-c与死亡结局的关联,中位随访7年。
主要发现
- 限制性立方样条显示LDL-c与全因死亡、癌症死亡及非癌非心血管死亡呈U形关系,最低点3.3-3.4 mmol/L。
- 心血管死亡风险在LDL-c低于3.3 mmol/L时相似,高于3.3 mmol/L时升高。
- 按LDL-c四分位分析观察到相似趋势。
- LDL-c每升高1 mmol/L,全因死亡风险降低9%,癌症死亡降低16%,非癌非心血管死亡降低18%,心血管死亡增加19%。
关键数值与推荐
- LDL-c与全因、癌症及非癌非心血管死亡的U形关系最低点为3.3-3.4 mmol/L。
- LDL-c每升高1 mmol/L对应全因死亡风险降低9%、癌症死亡降低16%、非癌非心血管死亡降低18%。
- LDL-c每升高1 mmol/L对应心血管死亡风险增加19%。
临床怎么用
- 对健康老年人评估LDL-c时应结合性别与心血管风险,不宜简单套用越低越好的降脂目标。
- LDL-c处于3.3-3.4 mmol/L附近时全因死亡风险最低,但高于该水平时心血管死亡风险升高,需个体化权衡。
- 男性与女性中LDL-c与死亡风险的关联存在差异,临床决策需考虑性别因素。
局限性
- 本研究为事后分析,结果需未来研究证实。
- 研究对象为无痴呆、失能、心血管病且未用降脂药的健康老年人,外推需谨慎。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The prognostic implication of cholesterol levels in older adults remains uncertain. This study aimed to examine the relationship between low-density-lipoprotein cholesterol (LDL-c) and mortality outcomes in older individuals. METHODS: This post hoc analysis examined the associations of LDL-c levels with mortality risks from all-cause, cardiovascular disease (CVD), cancer, and combined non-CVD/noncancer conditions in a cohort of individuals aged ≥65 years from the ASPirin in Reducing Events in the Elderly trial (NCT01038583). At baseline, participants had no diagnosed dementia, physical disability, or CVD, and were not taking lipid-lowering agents. Outcome analyses were performed using multivariable Cox models. RESULTS: We analyzed 12 334 participants (mean age: 75.2 years). Over a median 7-year follow-up, 1 250 died. Restricted cubic splines found a U-shaped relation for LDL-c and all-cause mortality, cancer mortality, and noncancer/non-CVE mortality (nadir: 3.3-3.4 mmol/L); the risk of CVD mortality was similar at LDL-c below 3.3 mmol/L and increased above 3.3 mmol/L. Similar trends were observed in analyses modeling LDL-c by quartiles. When modeling LDL-c as a continuous variable, the risk of all-cause mortality, cancer mortality, and noncancer/non-CVD mortality was decreased by 9%, 16%, and 18%, respectively, per 1-mmol/L higher LDL-c, and the risk of CVD mortality was increased by 19% per 1-mmol/L higher LDL-c. Reduced all-cause and non-CVD/noncancer mortality risks were only significant in males but not females (pinteraction < .05). CONCLUSIONS: There were U-shaped relationships between LDL-c and all-cause mortality, cancer mortality, and noncancer/non-CVD mortality in healthy older adults. Higher LDL-c levels were associated with an increased risk of CVD mortality. Future studies are warranted to confirm our results.
引用
- Zhou Z, Tonkin AM, Curtis AJ, et al. Low-Density-Lipoprotein Cholesterol and Mortality Outcomes Among Healthy Older Adults: A Post Hoc Analysis of ASPREE Trial. J Gerontol A Biol Sci Med Sci. 2024. PMID: 38038339. doi:10.1093/gerona/glad268
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。